Key result
US antiarrhythmic drug use increased from 2004 to 2016, demanding vigilance for safety and interactions.
Highlights the need for prescriber vigilance regarding the safety and interactions of increasingly used antiarrhythmic drugs in the US.
May warrant added vigilance on AAD interactions in practice; leaves open causal confirmation via prospective studies.
treated with AADs, and may limit AAD choice.It is essential that prescribers and other healthcare providers be vigilant about the safety profile, contraindications, and interactions of these increasingly used medications.
No takes yet. Share an insight, caveat, or question.
Markman et al. (2020) studied this question. Antiarrhythmic drug use increased in the US from 2004 to 2016, requiring providers to be vigilant about their safety, contraindications, and interactions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: